Medicinal and edible decoction as well as preparation method and application thereof

Through the medicinal and food decoction cream prepared by medicinal materials such as Huoshan Dendrobium, the problems of side effects and adverse reactions in the treatment of alcoholic liver and gastric mucosa in the prior art are solved, and a safe and efficient medicinal and food dual-use solution is provided, which is significantly Relieves the symptoms of alcoholic liver and gastric mucosa damage and has good liver protection and gastric activity.

CN118903323APending Publication Date: 2024-11-08WEST ANHUI UNIV +1
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202410958649.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-05-29
Filing Date
2024-07-17
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art has side effects and adverse reactions in the treatment of alcoholic liver and gastric mucosa injuries, and lacks a safe and effective application plan for both medicinal and food.

Method used

The two-purpose medicinal and food decoction cream prepared in a specific proportion of Huoshan Dendrobium, Luohan Fruit, Pueraria root, Citrus cerevisiae, Tangerine peel, hawthorn and licorice are used to extract the active ingredients through water heating extraction method, and mix them with honey and water to form suitable fluidity. Chinese herbal decoction cream with taste is used to prevent and treat alcoholic liver and gastric mucosa damage.

Benefits of technology

This decoction has the effects of sootheing the liver and stomach, nourishing the yin and relieving alcohol, which significantly relieves the symptoms of alcoholic liver damage and gastric mucosa damage. It has a good taste, moderate fluidity, and has good liver protection and gastric activity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903323A_ABST
    Figure CN118903323A_ABST
Patent Text Reader

Abstract

The invention relates to a medicinal and edible health product, and discloses a medicinal and edible decoction agent as well as a preparation method and application thereof, and the medicinal and edible decoction agent comprises the following raw materials in parts by weight: 12 parts of dendrobium huoshanense, 15 parts of momordica grosvenori, 15 parts of radix puerariae, 15 parts of semen hoveniae, 10 parts of pericarpium citri reticulatae, 12 parts of hawthorn and 10 parts of liquorice. The medicinal and edible decocted extract provided by the invention has the effects of soothing the liver, harmonizing the stomach, nourishing yin and dispelling the effects of alcohol, and can be used for relieving alcoholic liver injury, gastric mucosal injury and other symptoms.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a dual-purpose medicine and food health product, in particular to a dual-purpose medicine and food decoction paste and a preparation method and application thereof. Background Art

[0002] In my country, the drinking culture is profound and has a long history, but excessive alcohol intake can have serious negative effects on health, leading to more than 200 diseases of multiple organs such as the brain, heart, gastrointestinal tract and liver, and increasing the risk of cancer and death.

[0003] Western medicine has certain advantages in treating alcoholic liver and gastric mucosal damage and is effective quickly, but it also has side effects and adverse reactions. Chinese medicines that can be used as both medicine and food are highly safe, effective, and easily accepted by patients. They are also important raw materials for the development and production of Chinese medicine health foods. Therefore, it is necessary to apply Chinese medicines that can be used as both medicine and food to treat diseases such as alcoholic liver and gastric mucosal damage. Summary of the invention

[0004] The invention aims at the problems existing in the prior art and provides a medicinal and edible decoction and a preparation method and application thereof.

[0005] In order to solve the above technical problems, the present invention is solved by the following technical solutions:

[0006] A decoction for both medicinal and edible purposes comprises the following raw materials by weight: 12 parts of Huoshan dendrobium, 15 parts of momordica grosvenori, 15 parts of kudzu root, 15 parts of hovenia dulcis, 10 parts of tangerine peel, 12 parts of hawthorn and 10 parts of liquorice.

[0007] As a priority, honey and water are also included. By compounding an appropriate amount of honey, the obtained medicinal and edible decoction paste has a suitable taste.

[0008] As a preference, the decoction comprises 0-70 parts of honey and 20-100 parts of water by weight. The proportion of honey and water can make the decoction have moderate fluidity, good taste, and good liver protection and stomach activity.

[0009] A method for preparing a Chinese medicine decoction paste comprises the following steps:

[0010] Step S1, weighing raw materials according to the medicinal and edible decoction according to any one of claims 1 to 3;

[0011] Step S2, extracting the raw material weighed in step S1 by water heating extraction method to obtain an extract;

[0012] Step S3, filtering and concentrating to a clear paste with a relative density of the extract of 1.00 to 1.45, and mixing the clear paste with refined honey to obtain a mixed paste;

[0013] Step S4, heating and concentrating the mixed paste to a relative density of 1.05-1.30, and packaging while hot to obtain a Chinese medicine decoction paste.

[0014] As a preference, the water heating extraction method in step S2 specifically comprises the following steps:

[0015] Step S21, placing the raw material weighed in step S1 into an extraction device, and adding water at a material-liquid ratio of 1:10 to 1:15 g / mL to obtain a material-liquid mixture;

[0016] Step S22, heating the extraction device to evaporate the water and fully extract the target substance in the feed-liquid mixture;

[0017] Step S23, repeat step S22 1-2 times to obtain the final extract.

[0018] Preferably, the mixing ratio of the clear paste to the refined honey in step S3 is 1:1 to 1:5.

[0019] An application of a medicinal and edible decoction, wherein the aforementioned medicinal and edible decoction or the medicinal and edible decoction obtained by the aforementioned medicinal and edible decoction preparation method is applied to food / health food / drug for preventing / treating alcoholic liver or gastric mucosal damage.

[0020] An application of a medicinal and edible decoction, wherein the aforementioned medicinal and edible decoction or the medicinal and edible decoction prepared by the aforementioned medicinal and edible decoction preparation method is applied to food / health products / drugs for preventing / treating alcoholic liver or gastric mucosal damage.

[0021] The present invention has significant technical effects due to the adoption of the above technical solution:

[0022] The medicinal and edible decoction provided in the present invention has the effects of soothing the liver and stomach, nourishing yin and relieving alcohol, and can be used to relieve symptoms such as alcoholic liver damage and gastric mucosal damage. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 Characterization of the liver and stomach of the two groups of mice.

[0024] Figure 2 These are pathological sections of the liver of two groups of mice.

[0025] Figure 3 These are pathological sections of the stomach of two groups of mice.

[0026] Figure 4 Figure 2 Changes of ALT and AST levels in serum of two groups of mice.

[0027] Figure 5 For the standard curve.

[0028] Figure 6 The results are from a single factor experiment.

[0029] Figure 7 This is the finished product picture.

[0030] Figure 8 Check the diagram for insoluble matter.

[0031] Fig. 9 This is a thin layer chromatogram of tangerine peel.

[0032] Fig.10 This is a thin layer chromatogram of Pueraria root.

[0033] Fig.11 TLC of licorice

[0034] Fig.12 This is the standard curve of hesperidin.

[0035] Fig.13 Specificity chromatogram.

[0036] Fig.14 Characterization of mouse liver and stomach.

[0037] Fig.15 The changes of serum ALT, AST, IL-6 and TNF-α levels in each group of mice ( n=10).

[0038] Fig.16 These are pathological sections of the liver of mice in each group.

[0039] Fig.17 These are pathological sections of the stomach of mice in each group.

[0040] Among them, compared with the model control group, ** means P < 0.01, * means P < 0.05; compared with the blank group, ## means P < 0.01, # means p < 0.05. DETAILED DESCRIPTION

[0041] The present invention is further described in detail below in conjunction with the accompanying drawings and embodiments.

[0042] Example 1

[0043] The invention provides a traditional Chinese medicine decoction paste, which comprises the following important raw materials: Huoshan dendrobium, momordica grosvenori, kudzu root, hovenia dulcis fruit, tangerine peel, hawthorn and liquorice (12:15:15:15:10:12:10).

[0044] Unless otherwise specified, the present invention has no special requirements on the sources of the components or raw materials of the Chinese medicine decoction, and commercially available products known to those skilled in the art can be used.

[0045] The preparation method of the Chinese medicine decoction paste of the present invention preferably comprises the following steps: weighing the medicinal materials according to the prescription, adopting the water heating extraction method, soaking for 1 hour, the solid-liquid ratio is 1:15, the extraction time is 1-2 hours, the heating temperature is 70-100°C, extracting 3 times, filtering and concentrating the extract to a clear paste with a relative density of 1.20 (60°C) through a rotary evaporator, mixing evenly with refined honey in a ratio of 1:3, heating and concentrating to a relative density of 1.25 (60°C), and packaging while hot to obtain the product.

[0046] In the present invention, the two extraction processes of traditional water extraction, water extraction and alcohol extraction are more preferably the traditional water extraction.

[0047] In the present invention, the number of water extractions is preferably 1 to 3 times, more preferably 3 times; when the number of water extractions is 2 or 3 times, the filtrate is preferably the sum of the filtrates filtered after 2 or 3 decoctions; the time for each water extraction is preferably 1 to 2 hours, more preferably 1.5 hours; the material-liquid ratio for each water decoction is preferably 1:10 to 1:15 g / mL, more preferably 1:15 g / mL.

[0048] In the present invention, the clear paste density of the decoction paste is preferably 1.00-1.45 (60°C), more preferably 1.20; the condensed paste density of the decoction paste is preferably 1.06-1.30 (60°C), more preferably 1.25; the amount of refined honey added to the decoction paste is preferably 1:1-1:5 (60°C), more preferably 1:3.

[0049] In the present invention, a thin layer chromatography method for kudzu root and dried orange peel and a method for determining the hesperidin content are established.

[0050] In the present invention, a mouse model of acute liver injury and gastric mucosal injury induced by 50% ethanol was constructed, and the protective effects of different concentrations of the formula extract on acute alcoholic liver injury and gastric mucosal injury in mice were investigated.

[0051] In order to further illustrate the present invention, a Chinese medicine decoction and its preparation method and application provided by the present invention are described in detail below in conjunction with the accompanying drawings and examples, but they should not be construed as limiting the scope of protection of the present invention.

[0052] Example 1

[0053] A Chinese medicine decoction paste is prepared by the following steps: taking Huoshan dendrobium, momordica grosvenori, kudzu root, hovenia dulcis fruit, tangerine peel, hawthorn and liquorice (12:15:15:15:10:12:10). Appropriately crush, adopt heating extraction method, the solvent is water, the solid-liquid ratio is 1:15g / mL, soak for 1h, extract 3 times, the extraction time is 1.5h, the combined extract is filtered, concentrated by rotary evaporation and freeze-dried to obtain the Chinese medicine water extract; the Huoshan Dendrobium, Momordica grosvenori, Pueraria lobata, Hovenia dulcis, dried tangerine peel, hawthorn, and licorice were purchased from Huoshan Tianxia Zeyu Biotechnology Development Co., Ltd. (Batch No.: 20220622133612), Haozhou Cijitang Chinese Medicine Pieces Co., Ltd. (Batch No.: 220801), Anhui Jianyitang Chinese Medicine Pieces Co., Ltd. (Batch No.: 221101), Zhejiang Taizhou Yuji Chinese Medicine Pieces Co., Ltd. (Batch No.: 221201), Anhui Zhenrentang Chinese Medicine Technology Development Co., Ltd. (Batch No.: 221001), Anhui Zhenrentang Chinese Medicine Technology Development Co., Ltd. (220101).

[0054] Comparative Example 1

[0055] An alcohol-water extract is prepared by the following steps: take dried tangerine peel and hawthorn (10:12), crush them appropriately, use a heating extraction method, the solvent is 75% ethanol, the solid-liquid ratio is 1:15g / mL, soak for 1h, extract 3 times, the extraction time is 1.5h, the combined extracts are filtered, and the rotary evaporation is concentrated for use. Take Huoshan Dendrobium, Momordica grosvenori, Pueraria lobata, Hovenia dulcis, and Licorice (12:15:15:15:10), crush them appropriately, use a heating extraction method, the solvent is water, the solid-liquid ratio is 1:15g / mL, soak for 1h, extract 3 times, the extraction time is 1.5h, the combined extracts are filtered, the rotary evaporation is concentrated, and the ethanol extracts are concentrated again, and freeze-dried. The medicinal materials are consistent with Example 1.

[0056] Example 2

[0057] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio parameter is examined, and the solid-liquid ratio is 1:05 g / mL.

[0058] Example 3

[0059] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio parameter is examined, and the solid-liquid ratio is 1:10 g / mL.

[0060] Example 4

[0061] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio parameter is investigated, and the solid-liquid ratio is 1:20 g / mL.

[0062] Example 5

[0063] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio parameter is investigated, and the solid-liquid ratio is 1:25 g / mL.

[0064] Example 6

[0065] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the extraction time parameter is investigated, and the extraction time is 1 hour.

[0066] Example 7

[0067] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the extraction time parameter is investigated, and the extraction time is 2 hours.

[0068] Example 8

[0069] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the extraction time parameter is investigated, and the extraction time is 2.5 hours.

[0070] Example 9

[0071] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the extraction time parameter is examined, and the extraction time is 3 hours.

[0072] Example 10

[0073] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the extraction number parameter is examined, and the extraction number is once.

[0074] Embodiment 11

[0075] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the extraction times parameter is investigated, and the extraction times is twice.

[0076] Example 12

[0077] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the extraction number parameter is investigated, and the extraction number is four times.

[0078] Embodiment 13

[0079] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the extraction number parameter is examined, and the extraction number is five times.

[0080] Embodiment 14

[0081] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio is 1:05 g / mL, the extraction time is 1 hour, and the extraction number is 1 time.

[0082] Embodiment 15

[0083] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio is 1:05 g / mL, the extraction time is 1.5 h, and the extraction times are 3 times.

[0084] Example 16

[0085] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio is 1:05 g / mL, the extraction time is 2 h, and the extraction times are 2 times.

[0086] Embodiment 17

[0087] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio is 1:10 g / mL, the extraction time is 1 hour, and the extraction times are 3 times.

[0088] Embodiment 18

[0089] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio is 1:10 g / mL, the extraction time is 1.5 h, and the extraction times are 2 times.

[0090] Embodiment 19

[0091] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio is 1:10 g / mL, the extraction time is 2 h, and the extraction number is 1 time.

[0092] Embodiment 20

[0093] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio is 1:15 g / mL, the extraction time is 1 hour, and the extraction times are 2 times.

[0094] Embodiment 21

[0095] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio is 1:15 g / mL, the extraction time is 1.5 h, and the extraction number is 1 time.

[0096] Embodiment 22

[0097] A Chinese medicine decoction paste, the preparation method of which is similar to that of Example 1, except that the solid-liquid ratio is 1:15 g / mL, the extraction time is 2 h, and the extraction times are 3 times.

[0098] Embodiment 23

[0099] A preparation method of a Chinese medicine decoction ointment, the preparation method is as follows: weigh each medicinal material according to the prescription amount in Example 1, add 15 times of water, soak for 1 hour, extract for 1.5 hours, extract 3 times, filter and combine the filtrate, concentrate the filtrate to a relative density of 1.20 (60°C), add 1:3 refined honey, stir while adding, continue to concentrate to a relative density of 1.25 (60°C), pour into a container while hot, and obtain the Chinese medicine decoction ointment; the operation of refining honey is as follows: put the honey into a pot and heat it to completely melt it, skim off the foam on it with a spoon when boiling over high heat, until most of the water in the honey evaporates, large bubbles appear and it appears dark red, add an appropriate amount of cold water (water-honey ratio 1:3), continue to heat over low heat until boiling, and then pour it out while hot to obtain refined honey; the medicinal materials are consistent with those in Example 1, and the honey is purchased from Hubei Alita Health Industry Co., Ltd., batch number 20221002.

[0100] Embodiment 24

[0101] A method for preparing a Chinese medicine decoction ointment, the preparation method is similar to Example 23, the difference being that the clear ointment density parameter is optimized, wherein the clear ointment density is 1.00 (60°C).

[0102] Embodiment 25

[0103] A method for preparing a Chinese medicine decoction ointment, the preparation method is similar to Example 23, except that the density parameters of the clear ointment are optimized, wherein the density of the clear ointment is 1.13 (60°C).

[0104] Embodiment 26

[0105] A method for preparing a Chinese medicine decoction ointment, the preparation method is similar to Example 23, the difference being that the density parameters of the clear ointment are optimized, wherein the density of the clear ointment is 1.32 (60°C).

[0106] Embodiment 27

[0107] A method for preparing a Chinese medicine decoction ointment, the preparation method is similar to Example 23, except that the density parameters of the clear ointment are optimized, wherein the density of the clear ointment is 1.45 (60°C).

[0108] Embodiment 28

[0109] A method for preparing a Chinese medicine decoction paste, the preparation method is similar to Example 23, the difference being that the parameter of the amount of refined honey added is optimized, wherein the amount of refined honey added is 1:1.

[0110] Embodiment 29

[0111] A method for preparing a Chinese medicine decoction paste, the preparation method is similar to Example 23, the difference being that the parameter of the amount of refined honey added is optimized, wherein the amount of refined honey added is 1:2.

[0112] Embodiment 30

[0113] A method for preparing a Chinese medicine decoction paste, the preparation method is similar to Example 23, the difference being that the parameter of the amount of refined honey added is optimized, wherein the amount of refined honey added is 1:4.

[0114] Embodiment 31

[0115] A method for preparing a Chinese medicine decoction paste, the preparation method is similar to Example 23, the difference being that the parameter of the amount of refined honey added is optimized, wherein the amount of refined honey added is 1:5.

[0116] Embodiment 32

[0117] A method for preparing a Chinese medicine decoction ointment, the preparation method is similar to Example 23, the difference being that the ointment density parameter is optimized, wherein the ointment density is 1.06 (60°C).

[0118] Embodiment 33

[0119] A method for preparing a Chinese medicine decoction ointment, the preparation method is similar to Example 23, the difference being that the ointment density parameter is optimized, wherein the ointment density is 1.14 (60°C).

[0120] Embodiment 34

[0121] A method for preparing a Chinese medicine decoction ointment, the preparation method is similar to Example 23, the difference being that the ointment density parameter is optimized, wherein the ointment density is 1.20 (60°C).

[0122] Embodiment 35

[0123] A method for preparing a Chinese medicine decoction ointment, the preparation method is similar to Example 23, the difference being that the ointment density parameter is optimized, wherein the ointment density is 1.30 (60°C).

[0124] Comparative application example 1

[0125] Taking the liver and stomach protection activity as the evaluation index, the optimal extraction process was determined by comparing Example 1 and Comparative Example 1. The results showed that the liver and stomach protection activity of Example 1 was better than that of Comparative Example 1. The specific experimental scheme is as follows: After adaptive feeding for 3 days, the mice were randomly divided into 5 groups, and the dosage was determined according to the human and mouse body surface area conversion standard and the paste yield rate, namely, the blank control group, the model group, the Example 1 group (process route 1 group) (4732 mg / kg), the Comparative Example 1 group (process route 2 group) (4197.5 mg / kg), the positive group 1 (silymarin 143 mg / kg), the positive group 2 (omeprazole 130 mg / kg), and each group had 12 mice. Each group was given drugs by gavage at 10mL / kg body weight. The control group and the model group were given an equal volume of 0.05% CMC-Na solution once a day. After continuous gavage for 10 days, the mice were fasted but not watered for 16 hours. Except for the control group, the other groups were gavaged with 50% ethanol solution (15mL / kg) to establish the model. After 2 hours, the drugs were given by gavage to each group. 2 hours after the last gavage, blood was collected for subsequent testing. The blood was allowed to stand at room temperature for 2 hours, centrifuged at 4℃ and 3500r / min for 15 minutes, and the upper serum was taken. The content of AST and ALT in serum was determined by Elisa method. For specific operations, please refer to the instructions of Elisa kit. The mice were killed by cervical dislocation, and the liver was collected for subsequent testing. The liver was rinsed with frozen saline, and the left lobe of the liver was fixed in 4% paraformaldehyde. After 2 days, the sections were stained with HE, and the rest of the liver tissue was stored at -80℃ for testing.

[0126] Liver and stomach characteristics of the two groups of mice

[0127] like Figure 1 As shown, it can be seen with the naked eye that the gastric bleeding of the mice in the comparative example 1 group is more serious than that in the example 1 group, and the difference in liver damage is not obvious.

[0128] Pathological sections of liver and stomach of two groups of mice

[0129] like Figure 2 As shown, the hepatocytes in the blank group were large in size, rich in cytoplasm, and no obvious histopathological changes were observed. The hepatocytes in the model group were edematous, with pale cytoplasm (see black arrows), infiltration of inflammatory cells (see green arrows), fatty degeneration of hepatocytes, and round vacuoles (see yellow arrows) in the cytoplasm. The hepatocytes in Example 1 group were large in size, rich in cytoplasm, and no obvious histopathological changes were observed. The hepatocytes in the comparative example 1 group were large in size, rich in cytoplasm, fatty degeneration of hepatocytes, round vacuoles (see yellow arrows) in the cytoplasm, and infiltration of inflammatory cells (see green arrows).

[0130] like Figure 3As shown in the figure, the gastric mucosal hierarchical structure of the blank group is complete and clear, the glands are arranged closely and neatly, and no obvious histopathological changes are observed. The gastric mucosal epithelial cells of the model group are eroded (see green arrows), the glands of the lamina propria are atrophied, the number is reduced, the arrangement is loose and disordered (see black arrows), and the blood vessels are dilated and congested (see blue arrows). The number of glands in the lamina propria of the embodiment 1 group is increased compared with the model group, and they are arranged closely, and a small amount of inflammatory cells infiltrate the mucosal layer (see yellow arrows). The gastric gland parietal cells of the comparative example 1 group have partial edema (see black arrows), dilated and congested blood vessels (see blue arrows), and mild inflammatory cell infiltration (see yellow arrows).

[0131] Changes of ALT and AST levels in serum of two groups of mice

[0132] like Figure 4 As shown in Table 1, both process 1 and process 2 can reduce the ALT content in mouse serum, but process 2 is not significant. Both process 1 and process 2 can reduce the AST content in mouse serum and are significant.

[0133] Table 1 Changes of ALT and AST levels in mouse serum

[0134]

[0135] Note: Compared with the blank group, ##P<0.01; compared with the model group, *P<0.05, **P<0.01

[0136] Comparative Application Example 2

[0137] The total polysaccharide content and total flavonoid content were selected as two evaluation indicators to optimize Examples 1 to 13 to prepare Chinese medicine extracts, and the results were as follows. The total polysaccharide and total flavonoid content were determined as follows:

[0138] (1) Maximum absorption wavelength: Accurately pipette 1 mL of standard glucose solution and sample solution into stoppered test tubes, respectively. Accurately add 1 mL of 5% phenol solution to each tube and shake well. Accurately add 5 mL of concentrated sulfuric acid solution and quickly shake well. Heat in a boiling water bath for 20 min. Take out and cool in an ice water bath for 5 min. Measure over the entire wavelength range using a visible spectrophotometer to determine the maximum absorption wavelength.

[0139] Accurately transfer 1 mL of rutin standard solution and 1 mL of test solution into each 25 mL volumetric flask, add water to 6 mL each, add 1 mL of 5% sodium nitrite solution, shake well, let stand for 6 min, add 1 mL of 10% aluminum nitrate solution, shake well, let stand for 6 min, add 10 mL of 4% sodium hydroxide test solution, add water to the scale, shake well, let stand for 15 min, use the reagent blank as a reference, perform a full wavelength scan on a UV-visible spectrophotometer, and measure the maximum absorption wavelength.

[0140] (2) Drawing of glucose standard curve: Accurately weigh 10 mg of standard glucose reference substance dried to constant weight at 105°C into a 100 mL volumetric flask, add water to the mark, shake well, and pipette 0.1, 0.2, 0.4, 0.6, and 0.8 mL into 10 mL stoppered test tubes, add water to make up to 1 mL each, accurately add 1 mL of 5% phenol, shake well, and then accurately add 5 mL of concentrated sulfuric acid, shake well quickly, heat in a boiling water bath for 20 minutes, take out, cool in an ice water bath for 5 minutes, use the corresponding reagent as a blank according to the same color development operation, and measure the absorbance at the maximum absorption wavelength. The horizontal axis is the concentration, the vertical axis is the absorbance, and the standard curve is drawn, see Figure 4 .

[0141] (3) Determination of total polysaccharide content of the test sample: Take 0.1 g of the sample lyophilized powder and dissolve it in pure water in a 10 mL volumetric flask, ultrasonicate it to dissolve it, let it cool, add pure water to the scale, shake it well, take 1 mL of pure water and dilute it to the volume in a 50 mL volumetric flask to obtain the test sample solution, accurately pipette 0.5 mL of the test sample solution, add water to 1 mL, place it in a 10 mL stoppered test tube, add 1 mL of 5% phenol, shake it well, accurately add 5 mL of concentrated sulfuric acid, shake it quickly, heat it in a boiling water bath for 20 min, cool it in an ice bath for 5 min, measure the absorbance at the maximum absorption wavelength, and substituting the measured absorbance into the standard curve to obtain the total polysaccharide content.

[0142] (4) Drawing of rutin standard curve: Accurately weigh 5 mg of rutin reference substance dried to constant weight at 105°C, place in a 50 mL volumetric flask, add an appropriate amount of ethanol, sonicate to dissolve, cool, add ethanol to the mark, and shake well. Accurately measure 1 mL, 2 mL, 3 mL, 4 mL, 5 mL, and 6 mL of reference substance solution, place in 25 mL volumetric flasks, add water to 6 mL each, add 1 mL of 5% sodium nitrite solution, shake well, let stand for 6 min, add 1 mL of 10% aluminum nitrate solution, shake well, let stand for 6 min, add 10 mL of 4% sodium hydroxide test solution, add water to the mark, shake well, let stand for 15 min, use the corresponding reagent as blank, and immediately measure the absorbance at the maximum absorption wavelength by UV-visible spectrophotometry. Use absorbance as the ordinate and concentration as the abscissa to draw a standard curve, see. Figure 5 ,in Figure 5 A represents the glucose standard curve; B represents the Wie rutin standard curve.

[0143] (5) Determination of total flavonoid content of the test sample: Take 0.5 g of the sample lyophilized powder and dissolve it in pure water in a 5 mL volumetric flask, dissolve it by ultrasonic treatment, cool it, add ethanol to the scale, shake it well, and then get the test solution. Accurately measure 0.5 mL of the test solution and place it in a 25 mL volumetric flask, add water to 6 mL, add 1 mL of 5% sodium nitrite solution, shake it well, let it stand for 6 min, add 1 mL of 10% aluminum nitrate solution, shake it well, let it stand for 6 min, add 10 mL of 4% sodium hydroxide test solution, add water to the scale, shake it well, let it stand for 15 min, use the corresponding reagent as a blank, and immediately measure the absorbance at the maximum absorption wavelength by UV-visible spectrophotometry, and bring the measured absorbance into the standard curve to obtain the total flavonoid content.

[0144] Standard curve

[0145] Scanning at full wavelengths showed that the glucose reference substance had maximum absorption at 488nm and the rutin reference substance had maximum absorption at 500nm. Therefore, the wavelengths for total polysaccharide and total flavonoid determination were selected as 488nm and 500nm, respectively. The standard curves of glucose reference substance and rutin reference substance are shown in Figure 4 .

[0146] Single factor test results

[0147] like Figure 6 As shown in the figure, with the increase of solid-liquid ratio, extraction time and extraction times, the transfer rate of total flavonoids and total polysaccharides increased. When the solid-liquid ratio was 1:10 g / mL, the extraction time was 1.5 h and the extraction times were 2 times, the yield was the highest. When it exceeded 1:10 g / mL, 1.5 h and twice, the yield decreased. Therefore, solid-liquid ratios of 1:05, 1:10, 1:15 g / mL, extraction times of 1, 1.5, 2 h, and extraction times of 1, 2, and 3 times were selected as the three levels of the orthogonal experiment, as shown in the figure. Figure 6 As shown, A represents the solid-liquid ratio factor; B represents the number of extractions; and C represents the extraction time.

[0148] Comparative Application Example 3

[0149] A comprehensive score was established based on the three indicators of cream yield, total polysaccharide transfer rate, and total flavonoid transfer rate. The scoring criteria for the Chinese herbal extracts prepared in Examples 14 to 22 are as follows:

[0150] Comprehensive score (Yi) = (X1i / X1max×0.3+X2i / X2max×0.3+X3i / X3max×0.4)×100

[0151] Yi represents the comprehensive score value of the i-th orthogonal experiment, X1i, X2i, and X3i represent the total flavonoid transfer rate, total polysaccharide transfer rate, and paste yield rate of the i-th orthogonal experiment results, and X1max, X2max, and X3max represent the maximum values ​​of the total flavonoid transfer rate, total polysaccharide transfer rate, and paste yield rate in the orthogonal experiment results.

[0152] The calculation formulas for the paste yield and transfer rate are as follows:

[0153] Ointment yield = dry weight of test sample / total weight of medicinal materials × 100%

[0154] Transfer rate = (extract content x ointment yield) / medicinal material content

[0155] The rating results are as follows:

[0156] Table 2 Optimization results of decoction preparation process

[0157]

[0158] Table 3 Analysis of variance table

[0159]

[0160] From the range analysis (see Table 2), the order of influence of the three factors on the comprehensive score is: A (solid-liquid ratio) > C (number of extractions) > B (extraction time), indicating that the solid-liquid ratio has the greatest influence on the comprehensive score during the extraction process, and the extraction time has the least influence. From the table, it can be seen that the optimal extraction conditions are a solid-liquid ratio of 1:15g / mL, an extraction time of 1.5h, and three extractions. The order of factors obtained by variance analysis (Table 3) is consistent with the results of the range analysis, and the solid-liquid ratio and the number of extractions have a significant effect on the comprehensive score.

[0161] Based on the cream yield, total polysaccharide transfer rate, and total flavonoid transfer rate of Examples 14 to 22 of the present invention, the optimal preparation process is to weigh appropriate amounts of Dendrobium huoshanense, Momordica grosvenori, Pueraria root, Hovenia dulcis, dried orange peel, hawthorn, and liquorice (12:15:15:15:10:12:10), add 15 times of water, soak for 1 hour, heat and extract, the extraction time is 1.5 hours, and extract 3 times. According to this preparation process, 3 batches of Chinese medicine extracts were prepared for comprehensive scoring.

[0162] Table 4 Verification test results

[0163]

[0164] The total polysaccharide transfer rate, total flavonoid transfer rate and comprehensive score of the three batches in the verification test were close to the maximum values ​​of the evaluation indicators of the orthogonal test, which showed that the optimal process selected by the orthogonal test had good reproducibility, stability and reliability (see Table 4).

[0165] Comparative Example 3

[0166] Comprehensive evaluation was performed based on indicators such as appearance, taste, fluidity, and water solubility. The scoring criteria for Comparative Examples 23 to 35 are shown in Table 5, and the scoring results are shown in Table 6.

[0167] Table 5 Contents of the multi-index comprehensive scoring method

[0168]

[0169]

[0170] Table 6 Single factor test results of decoction paste formability

[0171]

[0172] The results showed that when the relative density of the clear paste was 1.20 and the relative density of the finished paste was 1.25, when 1:3 refined honey was added, the color was dark brown, the smell was slightly sweet, the taste was sweet, the viscosity was moderate, it had a certain fluidity, was semi-fluid, and the sensory score was high (see Table 6).

[0173] Taking into account the appearance, shape, viscosity, fluidity, etc. of Examples 23 to 35 of the present invention, the optimal preparation process is the Chinese medicine decoction prepared in Example 11. Three batches of Chinese medicine decoction were prepared according to the method described in Example 23, and scored according to the scoring criteria in Table 5. The results are shown in Table 7.

[0174] Table 7 Verification test results

[0175]

[0176] The results showed that the relative density and sensory scores of the three batches of decoction prepared in parallel were close to the evaluation indicators of the optimal process, indicating that the optimal process had good reproducibility, stability and reliability (see Table 7, Figure 7 ).

[0177] The quality standard of the three batches of samples obtained in Example 23 was studied by confirmatory tests, and the quality standard was established as follows:

[0178] (1) Relative density:

[0179] According to the method for determining the relative density of decoctions in the "People's Republic of China (2020 Edition)", the temperature is set at 60°C and the calculation formula is as follows.

[0180]

[0181] Wherein, w1 is the weight of the test solution in the pycnometer (g); w2 is the weight of the water in the pycnometer (g);

[0182]

[0183] (2) Insoluble matter detection: Take 5 g of three batches of Chinese medicine decoction, add 200 mL of hot water respectively, stir to dissolve, leave for 3 min, and observe whether there are foreign matters such as burnt debris.

[0184] (3) Tangerine peel thin layer identification: ① Preparation of test solution: Take 3g of decoction, add 10mL of methanol, ultrasonically treat for 20min, filter, take 5mL of filtrate, concentrate to 1mL, as test solution. Take 0.3g of tangerine peel control medicinal material powder and prepare control medicinal material solution in the same way. ② Preparation of negative test solution: Take a negative sample prepared according to the preparation process without tangerine peel, and prepare a negative test solution in the same way as the above test solution preparation method. ③ Preparation of reference solution: Accurately weigh the hesperidin reference substance and add methanol to prepare a reference solution with a concentration of 1mg / mL. ④ Thin layer chromatography operation: Take 10μL of the test solution, negative test solution, reference solution, and tangerine peel control medicinal material solution, respectively, and spot them on a silica gel G thin layer plate prepared with 0.5% sodium hydroxide solution. Ethyl acetate-methanol-concentrated ammonia solution-water (8:3:0.7:1) was used as the developing solvent, and the development was carried out upward with a development distance of about 8.5 cm. The silica gel G plate was taken out, dried at room temperature, sprayed with aluminum chloride test solution, dried, and inspected under ultraviolet light (365 nm). The methanol (analytical grade) used was purchased from Shanghai Zhanyun Chemical Co., Ltd., batch number: 220220; hesperidin standard (≥99.0%) was purchased from Sichuan Weikeqi Biotechnology Co., Ltd., batch number: 23010902; silica gel plate (0.5% NaOH) was purchased from Qingdao Ocean Chemical Co., Ltd., batch number: 20231006; ethyl acetate was purchased from Shanghai Zhanyun Chemical Co., Ltd., batch number: 220120; concentrated ammonia water was purchased from Chengdu Jinshan Chemical Reagent Co., Ltd., batch number: 20220312; aluminum chloride was purchased from Tianjin Damao Chemical Reagent Factory, batch number: 20220108.

[0185] (4) Pueraria lobata TLC Identification: ① Preparation of test solution: Take 2g of this product, add 50mL of methanol, ultrasonically treat for 30min, cool, add methanol to make up to 50mL, shake well and filter, accurately measure 1mL of filtrate, put it in a 10mL volumetric flask, add methanol to dissolve and dilute to the scale, shake well to obtain the test solution. Take another 1g of Pueraria lobata powder and prepare the control medicinal material solution in the same way. ② Preparation of negative test solution Take a negative sample without Pueraria lobata prepared according to the preparation process, and prepare a negative test solution in the same way as the above test solution preparation method. ③ Preparation of reference solution: Take puerarin reference substance, add methanol to make a solution containing 1mg per 1mL, as the reference solution. ④ Thin layer chromatography operation: 10 μL of the above-mentioned test solution, negative test solution, kudzu root reference medicinal material solution and 5 μL of reference solution were taken respectively, and spotted on a silica gel G thin layer plate to make it into strips, and chloroform-methanol-water (7:2.5:0.25) was used as a developing agent, poured into a developing cylinder and saturated for 15 minutes, and after saturation, the spotted thin layer plate was placed in the developing cylinder, and the development was stopped when it was 2 cm from the upper edge of the thin layer plate, and the thin layer plate was taken out, dried, and inspected under an ultraviolet lamp (254 nm). The puerarin standard (≥98.0%) was purchased from Shanghai McLean Biochemical Technology Co., Ltd., batch number: C14506801; chloroform was purchased from Sinopharm Chemical Reagents, batch number: 20220419, and the rest was the same as the reagents used for identification of tangerine peel thin layer.

[0186] (5) TLC identification of licorice: ① Preparation of test solution: Take 2g of this product, add 25mL of methanol, ultrasonically treat for 30min, cool, add methanol to make up for the weight loss, shake well and filter to obtain the test solution. ② Preparation of negative test solution: Take a negative sample prepared according to the preparation process without licorice, and prepare a negative test solution in the same way as the above test solution preparation method. ③ Preparation of reference solution: Take liquiritin reference, add methanol to make a solution containing 2mg per 1mL, as the reference solution. ④ Thin layer chromatography operation: Take 5μL of the above test solution, negative test solution, licorice reference medicinal material solution and reference solution, respectively, and spot them on a silica gel G thin layer plate to make strips, use chloroform-methanol (20:5) as the developing solvent, develop, take out, dry, spray with 5% vanillin sulfuric acid solution, heat at 105℃ until the spots are clearly colored, and inspect under sunlight. The liquiritin standard (≥98.0%) was purchased from Chengdu Mansite Biotechnology Co., Ltd., batch number: MUST-22061510; sulfuric acid was purchased from Xikong Chemical Co., Ltd., batch number: 2112301; vanillin was purchased from Shanghai MacLean Biochemical Technology Co., Ltd., batch number: C14841120, and the rest were the same as the reagents used for tangerine peel thin layer identification.

[0187] (6) Determination of hesperidin content: ① Chromatographic conditions: octadecylsilane bonded silica gel as filler; acetonitrile-water (20-80) as mobile phase, detection wavelength of 283nm, running time of 30min, flow rate of 1mL / min, column temperature of 30℃, accurately aspirate 10μL of reference solution, test solution and negative reference solution, inject into liquid chromatograph for determination. ② Preparation of reference solution: Take an appropriate amount of hesperidin reference, accurately weigh it, add methanol to make a solution with a concentration of 100, 300, 500, 700, 900, 1100, 1300μg / mL. ③ Preparation of test solution: Accurately weigh 3g of this product, 1.5g of diatomaceous earth, add 25mL of methanol, weigh it, heat in a water bath for extraction for 1h, weigh it again after cooling, make up the lost weight with methanol, shake well, filter, and take the filtrate. ④ Preparation of negative control solution: Take a negative sample without Pueraria root prepared according to the preparation process, and prepare the rest in the same way as the test solution. ⑤ Methodological investigation: (a) Preparation of standard curve: Accurately pipette 100, 300, 500, 700, 900, 1100, 1300 μg / mL of hesperidin reference solution, and inject and measure continuously 3 times according to the above chromatographic conditions. Draw the standard curve with the injection concentration (μg / mL) (X) as the abscissa and the average peak area (Y) as the ordinate, and obtain the regression equation, correlation coefficient and linear range. (b) Specificity test: Accurately pipette hesperidin reference solution (100 μg / mL), test solution, and negative control solution (lacking tangerine peel), and inject and measure according to the above chromatographic conditions. (c) Precision test: Accurately pipette hesperidin reference solution (100 μg / mL), inject and measure according to the above chromatographic conditions, record the hesperidin peak area, and calculate the RSD value. (d) Repeatability test: Take 6 portions of the same batch of Chinese medicine decoction, accurately weigh them, prepare the test solution as above, inject and measure according to the above chromatographic conditions, record the peak area of ​​hesperidin, and calculate the RSD value. (f) Stability test: Take the same portion of Chinese medicine decoction, accurately weigh them, prepare the test solution as above, inject and measure according to the above chromatographic conditions at 0, 2, 4, 6, 8, 12, 24, 36, and 48 hours, record the peak area, and calculate the average content and RSD value of hesperidin. (g) Intermediate precision test: Different operators use the same chromatograph to detect the content of the same batch of samples according to the above chromatographic conditions at different times. (h) Sample addition recovery test: Take 9 portions of the same batch of Chinese herbal decoction with known content, accurately weigh 1 g of each, and accurately add 0.5, 0.5, 0.5, 1, 1, 1, 1.5, 1.5, and 1.5 mL of hesperidin reference solution (concentration of 1.5166 mg / mL) at a ratio of 50%, 100%, and 150% of the hesperidin component contained in the Chinese herbal decoction, respectively. Prepare the test solution as above, and measure the sample under the above-mentioned chromatographic conditions, record the peak area, and calculate the average recovery rate and RSD value.

[0188] Sample recovery rate / % = (actual measured amount - original amount in the sample) / specified amount × 100%

[0189] (i) Sample content determination: Three different batches of Chinese medicine decoction were accurately weighed, and the test solution was prepared according to the above method. The sample was injected and determined under the above chromatographic conditions, and the peak area was recorded. The average content and RSD value of hesperidin in the samples were calculated.

[0190] The results are as follows:

[0191] (1) Relative density Weigh three batches of SG to test the relative density. The results show that the average relative density of the three batches of Chinese medicine decoction paste is 1.25 (see Table 8). The results show that the process of Shugan Jiejiu Paste is stable and the relative density meets the requirements.

[0192] Table 8 Relative density of three batches of decoction pastes

[0193]

[0194]

[0195] (2) Insoluble matter detection: According to the insoluble matter detection method under the decoction and paste item of the "Pharmacopoeia of the People's Republic of China (2020 Edition)", three batches of Chinese medicine decoction and paste were weighed in appropriate amounts to detect insoluble matter. The results showed that the three batches of Chinese medicine decoction and paste dissolved after adding hot water, and the color was reddish brown, with a slightly sweet smell. After standing for 3 minutes, no foreign matter such as burnt debris was found. The results showed that the liver-clearing and hangover-relieving paste had good solubility and no insoluble matter was found, which met the requirements (see Figure 8 ).

[0196] (3) TLC identification results of tangerine peel

[0197] The results showed that the test sample, the single herbal material of dried tangerine peel and the hesperidin reference substance had spots of the same color at the same position, and the negative control substance had no spots. Fig. 9 As shown, Fig. 9 1 represents the negative control; 2-4 represent 3 batches of test products; 5 represents hesperidin; 6 represents dried orange peel. The results show that this method can be used as a TLC identification exclusive for dried orange peel.

[0198] (4) TLC Identification Results of Puerariae Radix

[0199] The results showed that the test sample, the single herb Pueraria root and the puerarin reference substance had spots of the same color at the same position, and the negative control substance had no spots. Fig.10 ,in Fig.10 1 is the negative control; 2-4 are three batches of test products; 5 is puerarin; 6 is pueraria root. The results show that this method can be used as a TLC identification exclusive for pueraria root.

[0200] (5) TLC Identification Results of Licorice

[0201] The results showed that the test sample, licorice root and liquiritin reference substance had spots of the same color at the same position, and the negative control substance had no spots. Fig.11 ,in Fig.11 1 is the negative control; 2-4 are three batches of test products; 5 is liquiritin; 6 is licorice. The results show that this method can be used as a TLC identification exclusive for licorice.

[0202] (6) Determination of hesperidin content

[0203] (a) Standard curve

[0204] The standard curve was drawn with hesperidin concentration (mg / mL) as the abscissa and peak area (AU) as the ordinate, and the regression equation was obtained: y=11622x+77542 (R2=0.9997). The results showed that the concentration of hesperidin showed a good linear relationship in the range of 100-1300 μg / mL, such as Fig.12 shown.

[0205] (b) Specificity test

[0206] The results showed that the chromatographic peak of hesperidin in the reference solution was consistent with the chromatographic peak of hesperidin in the test solution, and no peak appeared at the chromatographic peak of hesperidin in the chromatogram of the negative control solution, indicating that there was no interfering component in the negative control solution (lacking tangerine peel) for the determination of hesperidin content. Fig.13 As shown, Fig.13 A represents hesperidin; C represents the test sample; and B represents the negative control. The results show that this method has good specificity.

[0207] (c) Precision test

[0208] The results showed that the RSD value of the chromatographic peak area of ​​hesperidin was 0.10% (n=6), indicating that the precision of the instrument was good (Table 9).

[0209] Table 9 Precision test results (n = 6)

[0210]

[0211] (d) Stability test

[0212] The hesperidin content in the test solution was continuously measured for 48 hours. The results showed that the average hesperidin content was 1.54 mg / g, and the RSD value was 1.59% (n=9), indicating that the test solution was stable within 48 hours (see Table 10).

[0213] Table 10 Stability test results (n=9)

[0214]

[0215] (e) Repeatability test

[0216] Six test sample solutions were prepared in parallel and their hesperidin content was determined. The results showed that the average content of hesperidin was 1.52 mg / g and the RSD value was 2.41% (n=6), indicating that the determination method had good repeatability (see Table 11).

[0217] Table 11 Repeatability test (n=6)

[0218]

[0219] (f) Intermediate precision test

[0220] Using the same HPLC, different operators tested the hesperidin content of the same batch of samples at different times. The results showed that the average hesperidin content measured by different operators at different times using the same instrument was 1.52 mg / g, and the RSD value was 2.66% (n=6), indicating that the intermediate precision of this method was good and met the requirements (Table 12).

[0221] Table 12 Intermediate precision test (n=6)

[0222]

[0223] (g) Sample recovery test

[0224] Nine sample solutions were prepared at 50%, 100%, and 150% of the hesperidin content, and the hesperidin content was determined, and the sample recovery rate and RSD value were calculated. The results showed that the sample recovery rates met the requirements of the "Pharmacopoeia of the People's Republic of China (2020 Edition)", indicating that the established method is accurate and reliable (see Table 13).

[0225] Table 13 Sample recovery test results (n = 9)

[0226]

[0227]

[0228] (h) Sample content determination

[0229] The results showed that the average content of hesperidin in the three batches was 1.55 mg / g, and the RSD value was 0.73% (see Table 14).

[0230] Table 14 Hesperidin content determination results (n=3)

[0231]

[0232] Application Example 1

[0233] Verify the hepatoprotective and stomach-nourishing activities of the traditional Chinese medicine extract prepared in Verification Example 1. The specific verification tests are as follows:

[0234] 84 SPF-grade ICR male mice, 5 weeks old, with a body weight of (20±2) g, were purchased from Henan Sk贝斯 Biotechnology Co., Ltd. (License number: SCXK(Yu)-2020-0005). The breeding conditions of the mice were as follows: the environmental temperature was (24±2) °C, the relative humidity was (50±10)%, the lighting was in a 12h / 12h day-night cycle, and they had free access to food and water. The animal experiments were carried out after being reviewed and approved by the Experimental Animal Ethics Committee of West Anhui University (Ethical approval number: 202401001).

[0235] Grouping and administration: The mice were randomly divided into a blank control group, a model group, a positive 1 group, a positive 2 group, a high-dose group, a medium-dose group, and a low-dose group, with 12 mice in each group. The body weight was recorded daily. The high-dose group was intragastrically administered 0.2 mL / mouse of the traditional Chinese medicine extract (9464 mg / kg), the medium-dose group was intragastrically administered 0.2 mL / mouse of the traditional Chinese medicine extract (4732 mg / kg), the low-dose group was intragastrically administered 0.2 mL / mouse of the Shugan Jiejiu formula extract (2366 mg / kg), the blank control group and the model group were intragastrically administered 0.2 mL / mouse of 0.05% CMC-Na (carboxymethyl cellulose sodium solution), the positive 1 group was intragastrically administered 0.2 mL / mouse of silymarin (143 mg / kg), and the positive 2 group was intragastrically administered 0.2 mL / mouse of omeprazole solution (130 mg / kg). They were intragastrically administered continuously for 11 days. After 10 intragastric administrations, the mice were fasted but allowed to drink water for 24 h. The mice were placed in a metabolic cage. Except for the blank group, the mice in the other groups were intragastrically administered 0.15 mL / 10 g of 50% ethanol. One hour later, the last intragastric administration was performed. One hour later, blood was collected by eye socket puncture, and then the mice were quickly decapitated. The liver and stomach tissues were taken out and photographed to observe the characteristics.

[0236] Gross observation showed that the stomach of the model group had bleeding, and the color of the liver was yellowish. The liver and stomach injuries in the administration groups were all improved, as Fig.14 shown.

[0237] Determination of mouse serum biochemical indexes: According to the instructions of the kit, the contents of ALT, AST, TNF-α, and IL-6 in the serum of each group of mice were detected. The results are shown in Table 15 and Fig.15 .

[0238] The results showed that compared with the normal group, the contents of serum ALT, AST, IL-6, and TNF-α in the model group mice were extremely significantly increased (P<0.01); compared with the model group, the above indexes in each administration group were decreased (P<0.01 or P<0.05), while the decrease in ALT content in the low-dose group was not significant (P>0.05) (see Fig.15 , Table 15), among which Fig.14Compared with the blank group##P<0.01; compared with the model group*P<0.05;**P<0.01.

[0239] Table 15 Effects of Chinese herbal extracts on serum ALT, AST, IL-6, and TNF-α in mice ( n=10)

[0240]

[0241] Pathological sections of mouse liver and stomach tissues: fix liver and stomach tissues, dehydrate and make them transparent, embed them in wax, slice and mount them, dewax them, stain them with hematoxylin-eosin (HE), dehydrate and make them transparent, seal them, and observe them.

[0242] The hepatocytes in the blank group were large in size, with abundant cytoplasm, and no obvious histopathological changes were observed. The hepatocytes in the model group were edematous, with lightly stained cytoplasm (see black arrows). Inflammatory cells aggregated and infiltrated (see green arrows). A small number of hepatocytes were fatty degenerated, and round vacuoles were visible in the cytoplasm (see yellow arrows). The hepatocytes in the silymarin group were large in size, with abundant cytoplasm, and a small number of hepatocytes were fatty degenerated, and round vacuoles were visible in the cytoplasm (see yellow arrows). The hepatocytes in the low-dose group were large in size, with abundant cytoplasm, and inflammatory cells aggregated and infiltrated (see green arrows). A small number of hepatocytes were fatty degenerated, and round vacuoles were visible in the cytoplasm (see yellow arrows). The hepatocytes in the medium-dose and high-dose groups were large in size, with abundant cytoplasm, and no obvious histopathological changes were observed, such as Fig.16 shown.

[0243] The gastric mucosal hierarchical structure of the blank group was complete and clear, the glands were arranged tightly and neatly, and no obvious histopathological changes were observed. In the model group, the gastric mucosal epithelial cells were eroded (see green arrows), the lamina propria glands were atrophied, the number decreased, the arrangement was loose and disordered (see black arrows), and the blood vessels were dilated and congested (see blue arrows). The number of lamina propria glands in the omeprazole group increased compared with the model group, and the local arrangement was slightly loose, accompanied by mild inflammatory cell infiltration (see yellow arrows). The lamina propria gland structure in the low-dose group was rich, and a small amount of inflammatory cell infiltration was visible between the glands (see yellow arrows). The number of lamina propria glands in the medium-dose group increased compared with the model group, and the arrangement was tight, with a small amount of inflammatory cell infiltration in the mucosal layer (see yellow arrows). The number of lamina propria glands in the high-dose group increased compared with the model group, and the number was abundant and the arrangement was tight. No inflammatory cell infiltration was observed in the mucosal layer, such as Fig.17 shown.

[0244] It is easy to understand that those skilled in the art can combine, split, reorganize, etc. the embodiments of the present application to obtain other embodiments based on one or several embodiments provided in the present application, and these embodiments do not exceed the protection scope of the present application.

[0245] In conclusion, the above is only a preferred embodiment of the present invention, and all equivalent changes and modifications made according to the scope of the patent application of the present invention should fall within the scope of the patent of the present invention.

Claims

1. A decoction for both medicinal and edible purposes, comprising the following raw materials by weight: 12 parts of Huoshan dendrobium, 15 parts of momordica grosvenori, 15 parts of kudzu root, 15 parts of hovenia dulcis, 10 parts of tangerine peel, 12 parts of hawthorn, and 10 parts of liquorice.

2. A medicinal and edible decoction according to claim 1, characterized in that: Also includes honey and water.

3. A medicinal and edible decoction according to claim 2, characterized in that: The invention comprises 0 to 70 parts of honey and 20 to 100 parts of water by weight.

4. A method for preparing a Chinese medicine decoction paste, characterized in that: It includes the following steps: Step S1, weighing raw materials according to the medicinal and edible decoction according to any one of claims 1 to 3; Step S2, extracting the raw material weighed in step S1 by water heating extraction method to obtain an extract; Step S3, filtering and concentrating to a clear paste with a relative density of the extract of 1.00 to 1.45, and mixing the clear paste with refined honey to obtain a mixed paste; Step S4, heating and concentrating the mixed paste to a relative density of 1.05-1.30, and packaging while hot to obtain a Chinese medicine decoction paste.

5. A method for preparing a Chinese medicine decoction paste according to claim 4, characterized in that: The water heating extraction method in step S2 specifically comprises the following steps: Step S21, placing the raw material weighed in step S1 into an extraction device, and adding water at a material-liquid ratio of 1:10 to 1:15 g / mL to obtain a material-liquid mixture; Step S22, heating the extraction device to evaporate the water and fully extract the target substance in the feed-liquid mixture; Step S23, repeat step S22 1-2 times to obtain the final extract.

6. The method for preparing a medicinal and edible decoction according to claim 4, characterized in that: In step S3, the mixing ratio of the clear paste to the refined honey is 1:1 to 1:

5.

7. An application of a decoction for both medicinal and edible use, characterized in that: The edible and medicinal decoction paste described in any one of claims 1 to 3 or the edible and medicinal decoction paste prepared by the edible and medicinal decoction paste preparation method described in any one of claims 4 to 6 is applied to food / health food / drug for preventing / treating alcoholic liver or gastric mucosal damage.

Citation Information

Patent Citations

  • Health product for sobering up and relieving alcohol

    CN101791380A

  • Anti-alcohol and liver-protection traditional Chinese medicine composition and preparation method thereof

    CN103505563A

  • Anti-inebriation and anti-alcohol homologous traditional Chinese medicine composition and preparation method of traditional Chinese medicine composition

    CN108434231A

  • Liver-protecting and alcohol-dispelling beverage and preparation method thereof

    CN111567706A

  • Dendrobium huoshanense herb liver-protecting stomach-nourishing tea bag and preparation method thereof

    CN113475608A